Hanall Biopharma Co., Ltd.

Hanall Biopharma Co., Ltd.

009420.KS
Hanall Biopharma Co., Ltd.KR flagKorea Exchange
55,200.00
KRW
-2,200.00
- -
2.81TMarket Cap

Hanall Biopharma Co., Ltd. (009420.KS) Stock Split History

Learn about Hanall Biopharma Co., Ltd.'s most recent 10-for-1 basis stock split on May 03, 2006. Understand the impact on shareholders and the company's market position.

APIChatGPT

Latest Stock Split Details

Key information about Hanall Biopharma Co., Ltd.'s most recent stock split

Split Date: 2006-05-03
Split Ratio: 10:1
Price Before Split: $16878.61
Price After Split: $1687.86

Developer API

Get 009420.KS split history as JSON

Dates, ratios, split factors, and pre/post-split prices from a single REST call. Look up by ticker, CIK, CUSIP, or ISIN. Free tier, no scraping.

GETapi.roic.ai/v2/stock-splits/009420.KS

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 10.00 times more shares (a 10:1 ratio)
  • The price per share is reduced proportionally

Historical Stock Splits

A comprehensive history of Hanall Biopharma Co., Ltd.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2006-05-0310:1No$16878.61$1687.86

About Hanall Biopharma Co., Ltd.

Company overview and industry information

Hanall Biopharma Co., Ltd. (009420.KS) operates in the Medical - Pharmaceuticals industry. The recent 10-for-1 stock split reflects the company's growth and strategy to make shares more accessible to a broader range of investors.

Medical - Pharmaceuticals
Go to Hanall Biopharma Co., Ltd. Summary

Last updated: 7/13/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.